A Study of Carilizumab in Combination With Apatinib in Subjects With Unresectable UPS and ASPS
Clinical trial NCT04447274 · UNKNOWN
Trial details
- NCT number
- NCT04447274
- Sponsor
- Chinese Academy of Medical Sciences
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-07-01
- Primary completion
- 2021-12-31
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.